SLFN11 and cancer: SLFN11 is detected as one of the top predictors of response to SN-38 by the DepMap initiative [14, 15], with low SLFN11 expression being associated with a decreased sensitivity to SN-38 in 411 pan-cancer cell models (Fig. S8A–B).